FIELD: chemistry.
SUBSTANCE: invention relates to a compound (S)-2-ethoxy-3-(4-(4-alkoxyphenethoxy)-phenyl) propanoic acid 3a-g of the following structure: 
,
for therapy of metabolic syndrome.
EFFECT: novel compounds which can be used for therapy of metabolic syndrome are obtained.
1 cl, 10 dwg, 1 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| (2S)-3-(4-{2-[4-(2-{[(1R,4AR,7S)-7-ETHYNYL-1,4A,7-TRIMETHYL-1,2,3,4,4A,4B,5,6,7,8,10,10A-DODECAHYDROPHENANTHREN-1-YL]FORMAMIDO}ETHOXY)PHENYL]ETHOXY}PHENYL)-2-ETHOXY-PROPANOIC ACID FOR THERAPY AND PREVENTION OF METABOLIC SYNDROME | 2023 |
|
RU2813464C1 |
| N-[3-OXOLUP-28-OYL]-2-(4-(2-(4-((S)-2-ETHOXY-3-PROPANOYL)PHENOXY)ETHYL)PHENOXY)ETHANAMIDE FOR TREATING AND PREVENTING METABOLIC SYNDROME | 2021 |
|
RU2774591C1 |
| METHOD OF PRODUCING TETRASUBSTITUTED 4-DIAZO-5,5-DIALKYL-2,2-DIARYLDIHYDROFURAN-3(2H)-ONES | 2014 |
|
RU2562247C1 |
| PIPERIDINE DERIVATIVES AS GPR119 AGONISTS | 2013 |
|
RU2603346C2 |
| PYRROL[2,3-B]PYRAZINES AS SYK INHIBITORS | 2013 |
|
RU2656853C2 |
| AGENT FOR INCREASING THE SENSITIVITY OF TISSUES TO INSULIN IN TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2798603C1 |
| PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS FOR APPLICATION | 2012 |
|
RU2638552C2 |
| BRUTON'S TYROSINE KINASE INHIBITORS | 2014 |
|
RU2648236C2 |
| BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2597364C2 |
| ARYLSULFONYLMETHYL OR ARYLSULFONAMIDE DERIVATIVES OF AROMATICS, PHARMACEUTICAL COMPOSITION BASED ON THEM AND WAY OF TREATMENT AGAINST ABNORMALITIES RESPONSIVE TO DOPAMINE D RECEPTOR LIGAND TREATMENT, WITH THEIR HELP | 2005 |
|
RU2442781C2 |
